210 related articles for article (PubMed ID: 35887382)
21. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Behjati S; Tarpey PS; Haase K; Ye H; Young MD; Alexandrov LB; Farndon SJ; Collord G; Wedge DC; Martincorena I; Cooke SL; Davies H; Mifsud W; Lidgren M; Martin S; Latimer C; Maddison M; Butler AP; Teague JW; Pillay N; Shlien A; McDermott U; Futreal PA; Baumhoer D; Zaikova O; Bjerkehagen B; Myklebost O; Amary MF; Tirabosco R; Van Loo P; Stratton MR; Flanagan AM; Campbell PJ
Nat Commun; 2017 Jun; 8():15936. PubMed ID: 28643781
[TBL] [Abstract][Full Text] [Related]
22. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
23. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
24. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
25. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
27. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
[TBL] [Abstract][Full Text] [Related]
28. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
Wang Q
Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
[TBL] [Abstract][Full Text] [Related]
29. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
Li RZ; Wang LM
World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
[TBL] [Abstract][Full Text] [Related]
30. Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
Cai P; Lu Y; Yin Z; Wang X; Zhou X; Li Z
Biomed Res Int; 2021; 2021():6885897. PubMed ID: 34307667
[TBL] [Abstract][Full Text] [Related]
31. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
Chen G; Wang M; Liu X
Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
[TBL] [Abstract][Full Text] [Related]
32. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
Zhao H; Li M; Li L; Yang X; Lan G; Zhang Y
PLoS One; 2013; 8(12):e83571. PubMed ID: 24391788
[TBL] [Abstract][Full Text] [Related]
33. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data.
Kuijjer ML; Rydbeck H; Kresse SH; Buddingh EP; Lid AB; Roelofs H; Bürger H; Myklebost O; Hogendoorn PC; Meza-Zepeda LA; Cleton-Jansen AM
Genes Chromosomes Cancer; 2012 Jul; 51(7):696-706. PubMed ID: 22454324
[TBL] [Abstract][Full Text] [Related]
34. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
[TBL] [Abstract][Full Text] [Related]
36. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R.
Zhang Z; Zhao M; Wang G
J Cell Physiol; 2019 Dec; 234(12):22195-22206. PubMed ID: 31102265
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas.
Lin F; Shen Z; Xu X; Hu BB; Meerani S; Tang LN; Zheng SE; Sun YJ; Min DL; Yao Y
Int J Immunopathol Pharmacol; 2013; 26(1):169-77. PubMed ID: 23527719
[TBL] [Abstract][Full Text] [Related]
39. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
[TBL] [Abstract][Full Text] [Related]
40. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
